Nadav Kidron - Feb 11, 2025 Form 4 Insider Report for ORAMED PHARMACEUTICALS INC. (ORMP)

Role
President and CEO, Director
Signature
/s/ Nadav Kidron
Stock symbol
ORMP
Transactions as of
Feb 11, 2025
Transactions value $
$0
Form type
4
Date filed
2/11/2025, 04:31 PM
Previous filing
Jan 6, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORMP Common Stock Award $0 +141K +6.24% $0.00 2.4M Feb 11, 2025 Direct F1
transaction ORMP Common Stock Award $0 +186K +7.75% $0.00 2.59M Feb 11, 2025 Direct F2
transaction ORMP Common Stock Award $0 +100K +3.87% $0.00 2.69M Feb 11, 2025 Direct F3
holding ORMP Common Stock 126K Feb 11, 2025 By wholly-owned corporation
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares issued on settlement of performance stock units ("PSUs") previously granted on January 4, 2024 that vested on February 11, 2025 based on the achievement of the applicable performance criteria.
F2 Represents shares issued on settlement of PSUs previously granted on January 2, 2025 that vested on February 11, 2025 based on the achievement of the applicable performance criteria.
F3 Represents shares issued on settlement of PSUs previously granted on February 3, 2025 that vested on February 11, 2025 based on the achievement of the applicable performance criteria.